Outcomes Studies' Unsettling Questions
That managed care, as an industry, has focused more on managing costs than on managing care only serves to point out how powerful the effective management of information can be. The new Jericho program launched by Cardinal Health Inc., the large drug distributor, combines drug dispensing technology with outcomes analysis. Jericho aims to help hospital pharmacists determine which of several competing branded drugs ultimately results in the best care.
You may also be interested in...
Stand-alone bill headed for Senate, where it fared poorly in coronavirus response legislative packages.
Pfizer was heavily invested in immuno-oncology combinations five years ago, but following setbacks, the pipeline has shifted considerably, shaped partly by the acquisition of Array.
The possibility, which seems driven by the culture of the times, may be legally possible, but experts raised many practical concerns.